Schroder Ventures is the famous VC, which was founded in 1804. The main office of represented VC is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Schroder Ventures, startups are often financed by A.G. Edwards Capital Partners, InterWest Partners, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Abingworth, Atlas Venture, A.G. Edwards Capital Partners. In the next rounds fund is usually obtained by SV Health Investors, Oakwood Medical Investors, Fletcher Spaght, Inc..
This organization was formed by Nicholas Ferguson.
Among the most popular portfolio startups of the fund, we may highlight Auxilium Pharmaceuticals, Dynogen Pharmaceuticals, Avera Pharmaceutical. Among the most popular fund investment industries, there are Therapeutics, Medical. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. When the investment is from Schroder Ventures the average startup value is 10-50 millions dollars. The important activity for fund was in 2004. The real fund results show that this VC is 7 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Schroder Ventures performs on 24 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2017.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Brightbridge Ventures | England, London, United Kingdom |
| FF Estate AG | - |
| Green Arrow Capital | Italy, Lombardy, Milan |
| Hangzhou Maikasha | China, Hangzhou, Zhejiang |
| Industrial Investment Corporation | - |
| Jove Capital | - |
| Listwin Ventures | - |
| MAS Holdings | Colombo, Sri Lanka, Western Province |
| Sanlam | Gauteng, Johannesburg, South Africa |
| Social Ventures Australia | Australia, New South Wales, Sydney |
| Thermo Fisher Scientific | Massachusetts, United States, Waltham |
| Topcon Corp. | Japan, Tokyo |
| Triangle Capital Corporation | North Carolina, Raleigh, United States |
| University of Antwerp | Antwerp, Antwerpen, Belgium |
| University of California, Berkeley | Berkeley, California, United States |
| Votorantim Novos Negocios | Brazil, São Paulo, Sao Paulo |
| West Fund | Beijing, Beijing, China |
| Yuanchi Touzi | China, Shanghai |
| Zhoutong Touzi | Baoshan, China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $6M | 28 Aug 2008 | South Oxfordshire, England, United Kingdom | |||
| $34M | 19 Oct 2005 | Cambridge, England, United Kingdom | |||
| $1M | 15 Jul 2005 | City of Saint Louis, Missouri, United States | |||
Medifacts International | $16M | 27 Jan 2005 | Maryland, United States | ||
| $902K | 14 Oct 2004 | City of Saint Louis, Missouri, United States | |||
Solexa | $14M | 29 Sep 2004 | Hayward, California, United States | ||
| $48M | 05 Aug 2004 | Carlsbad, California, United States | |||
Rejuvenon | $37M | 23 Jun 2004 | The Woodlands, Texas, United States | ||
Sadra Medical | $9M | 17 Jun 2004 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $6M | 28 Aug 2008 | South Oxfordshire, England, United Kingdom | |||
| $34M | 19 Oct 2005 | Cambridge, England, United Kingdom | |||
| $1M | 15 Jul 2005 | City of Saint Louis, Missouri, United States | |||
Medifacts International | $16M | 27 Jan 2005 | Maryland, United States | ||
| $902K | 14 Oct 2004 | City of Saint Louis, Missouri, United States | |||
Solexa | $14M | 29 Sep 2004 | Hayward, California, United States | ||
| $48M | 05 Aug 2004 | Carlsbad, California, United States | |||
Rejuvenon | $37M | 23 Jun 2004 | The Woodlands, Texas, United States | ||
Sadra Medical | $9M | 17 Jun 2004 | California, United States |
